Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aratana Therapeutics

Request full access

Develops and markets innovative therapeutics for pets

Leawood, United StatesFounded 2010Biotech & Life Sciences

About Aratana Therapeutics

Aratana Therapeutics, now part of Elanco, specializes in developing and commercializing innovative therapeutics for pets. The company focuses on providing solutions that improve the health and quality of life for companion animals, including dogs and cats. Aratana operates in the animal health market, serving veterinarians and pet owners who seek advanced treatments for their pets. The business model revolves around the research, development, and commercialization of veterinary pharmaceuticals, which are sold through veterinary clinics and pet hospitals. Revenue is generated primarily through the sale of these therapeutic products. Aratana's portfolio includes treatments for pain management, cancer, and other chronic conditions in pets. The company leverages its expertise in veterinary medicine to address unmet medical needs in the pet care industry.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2013
Employees
16
Open positions
None listed
Dealroom signal
28.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Veterinary, Biotechnology, Oncology, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Jan 2014
Capital deployed
—
Preferred round
ACQUISITION

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Jul 2019 $0 — Elanco ↗
POST IPO EQUITY✓Other financing Mar 2018 $12M — Undisclosed —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Aratana Therapeutics website traffic

Latest recorded traffic for Aratana Therapeutics is 100 monthly website visits, down 33.3% over the last three months. Aratana Therapeutics's team grew 0% over the past year.

Latest monthly visits100 3-month web change-33.3% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Aratana Therapeutics in the Leawood ecosystem

Live from Dealroom

The Aratana Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • MPM BioImpact
  • Avalon Ventures

Series B and later3 investors entered at this stage

  • Kansas Bioscience Authority
  • Midwest Venture Alliance
  • Middleland Capital

Other known investors5 additional known investors

  • Elanco
  • KU Leuven
  • Cultivian Sandbox Ventures
  • Gemma Frisius Fund - GFF
  • Women's Capital Connection
Team profiled 22 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aratana Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aratana Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.